Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-14-021725
Filing Date
2014-04-10
Accepted
2014-04-10 09:10:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 v374301_424b3.htm 424B3 1326001
  Complete submission text file 0001144204-14-021725.txt   1327053
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-190897 | Film No.: 14755007
SIC: 2834 Pharmaceutical Preparations